Clinical Trial Update: Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis [NA]

View source ↗

Summary

A clinical trial is recruiting to assess whether anisodamine hydrobromide combined with low-molecular-weight heparin is effective in treating sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Anisodamine Hydrobromide (anisodamine hydrobromide)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Chen Ying | Conditions: Sepsis | NA | Status: RECRUITING